2022 ADA Guideline Expansion on CGM Recommendations and The Impact to Patients with T2D
At the completion of this session the audience will be able to recognize the importance of a CGM, how it is beneficial in the T2D population, and its impact on the hypoglycemia prevention and preparedness.
Date of Last Review: August 05, 2022
Document Number: VV-MED-121523
Are you satisfied with this content?